Pro- and anti-apoptotic dual functions of the C5a receptor: Involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase

Laboratory Investigation

Volumn 89, Issue 6, 2009, Pages 676-694

  Nishiura, Hiroshi ^a   Nonaka, Hideo ^a   Revollo, Ivette S ^a   Semba, Umeko ^a   Li, Ying ^a   Ota, Yoshihiko ^a   Irie, Atsushi ^a   Harada, Kumiko ^a   Kehrl, John H ^b   Yamamoto, Tetsuro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Apoptosis; C5a; C5a receptor; Extracellular signal regulated kinase; Regulator of G protein signaling 3; Ribosomal protein S19

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; DIMER; GUANINE NUCLEOTIDE BINDING PROTEIN; HOMODIMER; LIGAND; MANGANESE; MITOGEN ACTIVATED PROTEIN KINASE; RGS PROTEIN; RGS3 PROTEIN; RIBOSOMAL PROTEIN S19; RIBOSOME PROTEIN; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CELL STRAIN HL 60; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPERTHERMIA; KNOCKOUT GENE; LIFESPAN; MODULATION; MOUSE; NONHUMAN; PANCREAS; PARACRINE SIGNALING; POLYMER PRODUCTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CHEMOTAXIS, LEUKOCYTE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; GTPASE-ACTIVATING PROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTOR, ANAPHYLATOXIN C5A; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION;

EID: 66549093518     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.27     Document Type: Article

References (55)

1. Nishiura H, Shibuya Y, Matsubara S, et al Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein. J Biol Chem 1996;271:878-882.
2. Shi L, Tsurusaki S, Futa N, et al Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion. Virchow Arch 2005;447:747-755.
3. Nishiura H, Tanase S, Sibuya Y, et al Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest 1999;79:915-923.
4. Umeda Y, Shibuya Y, Semba U, et al Guinea pig S19 ribosomal protein as precursor of C5a receptor-directed monocyte-selective leukocyte chemotactic factor. Inflamm Res 2004;53:623-630.
5. Shrestha A, Horino K, Nishiura H, et al Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab Invest 1999;79:1629-1642.
6. Nishiura H, Shibuya Y, Yamamoto T. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab Invest 1998;78:1615-1623.
7. Shibuya Y, Shiokawa M, Nishiura H, et al Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer. Am J Pathol 2001;159:2293-2301.
8. Shrestha A, Shiokawa M, Nishimura T, et al Switch moiety in agonist/ antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor. Am J Pathol 2003;162:1381-1388.
9. Horino K, Nishiura H, Osako T, et al A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest 1998;78:603-617.
10. Nishimura T, Horino K, Nishiura H, et al Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J Biochem (Tokyo) 2001;129:445-454.
11. Nishiura H, Tanase S, Shibuya Y, et al S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor. J Cell Biochem 2005;94:540-553.
12. Yamamoto T. Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer. Pathol Int 2000;50:863-871.
13. Perianayagam MC, Barakrishnan VS, King AJ, et al C5a delays apoptosis of human neutrophils by a phosphatidyl inositol 3-kinase-signaling pathway. Kidney Int 2002;61:456-463.
14. Eastman A. The mechanism of action of cisplatin: from adducts to apoptosis. In: B Lippert (ed). Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug 1999. Wiley-VCH: Basel, Switzerland, pp 111-134.
15. Gonzalez VM, Fuertes MA, Alonso C, et al Is cisplatin-Induced cell death always produced by apoptosis? Mol Pharmacol 2001;59: 657-663.
16. Solito E, Kamal A, Russo-Marie F, et al A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J 2003;17:1544-1546.
17. Maderna P, Yona S, Perretti M, et al Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J Immunol 2005;174:3727-3733.
18. Arur S, Uche UE, Rezaul K, et al Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003;4:592-598.
19. Rescher U, Danielczyk A, Markoff A, et al Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol 2002;169:1500-1504.
20. Perretti M, Croxtall JD, Wheller SK, et al Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 1996;2:1259-1262.
21. Lim LH, Solito E, Russo-Marie F, et al Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci USA 1998;95:14535-14539.
22. Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007;21:968-975.
23. Revollo I, Nishiura H, Shibuya Y, et al Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes. Inflamm Res 2005;54:82-90.
24. Oda Y, Tokita K, Ota Y, et al Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J Biochem (Tokyo) 2008;144:371-381.
25. Oubrahim H, Chock PB, Stadtman ER. Manganese (II) induces apoptotic cell death in NIH3T3 cells via a caspase-12-dependent pathway. J Biol Chem 2002;277:20135-20138.
26. Futami T, Miyagishi M, Taira K. Identification of a network involved in thapsigargin-induced apoptosis using a library of small interfering RNA expression vectors. J Biol Chem 2005;280:826-831.
27. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 2003;64:1271-1276.
28. Dragovich T, Rudin CM, Thompson CB. Signal transduction pathways that regulate cell survival and cell death. Oncogene 1998;17:3207-3213.
29. Papazisis D, Zambouli OT, Kimoundri ES, et al Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation. Cancer Lett 2000;160:107-113.
30. Matsubara S, Yamamoto T, Tsuruta T, et al Complement C4-derived monocyte-directed chemotaxis-inhibitory factor: A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am J Pathol 1991;138:1279-1291.
31. Falk W, Goldwin RH, Leonard EJ. A 48 well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980;33:239-247.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
33. Konteatis ZD, Siciliano SJ, Van Riper G, et al Development of C5a receptor antagonists: differential loss of functional responses. J Immunol 1994;153:4200-4205.
34. Greasley PJ, Clapham JC. Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing? Eur J Pharmacol 2006;553:1-9.
35. Cotecchia S. Constitutive activity and inverse agonism at the alpha1adrenoceptors. Biochem Pharmacol 2007;73:1076-1083.
36. Pease JE, Burton DR, Barker MD. Generation of chimeric C5a/formyl peptide receptors: towards the identification of the human C5a receptor binding site. Eur J Immunol 1994;24:211-215.
37. Mery L, Boulay F. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. J Biol Chem 1994;269:3457-3463.
38. Han JI, Huang NN, Kim DU, et al RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J Leuko Biol 2006;79:1357-1368.
39. Niu J, Scheschonka A, Druey KM, et al RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain. Biochem J 2002;365:677-684.
40. Hunt JR, Martin CB, Martin BK. Transcriptional regulation of the murine C5a receptor gene: NF-Y is required for basal and LPS induced expression in macrophages and endothelial cells. Mol Immunol 2005;42:1405-1415.
41. Kabe Y, Yamada J, Uga H, et al NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol Cell Biol 2005;25:512-522.
42. Hirose T, Sowa Y, Takahashi S, et al p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 2003;22: 7762-7773.
43. Butler LM, Zhou X, Xu WS, et al The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 2002;99:11700-11705.
44. Huang W, Zhao S, Ammanamanchi S, et al Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J Biol Chem 2005;280:10047-10054.
45. Lalli PN, Strainic MG, Yang M, et al Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008;112:1759-1766.
46. Perianayagam MC, Barakrishnan VS, Pereira BJG, et al C5a delays apoptosis of human neutrophils via an extracellular signal-regulated kinase and Bad-mediated signaling pathway. Eur J Clin Invest 2004;34:50-56.
47. Suvorova SE, Gripentrog MJ, Oppermann M, et al Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor. BBA 2008;1783:1261-1270.
48. Gerard NP, Lu B, Liu P, et al An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 2005;280:39677-39680.
49. MacLaren R, Cui W, Cianflone K. Adipokines and the immune system: an adipocentric view. Adv Exp Med Biol 2008;632:1-21.
50. Monk PN, Scola A-M, Madala P, et al Function, structure and therapeutic potential of complement C5a receptors. Br J Pharm 2007;152:429-448.
51. Scannell M, Flanagan MB, deStefani A, et al Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 2007;178: 4595-4605.
52. van den Berg RH, Faber-Krol MC, van Wetering S, et al Inhibition of activation of classical pathway of complement by human neutrophil defensins. Blood 1998;92:3898-3903.
53. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995;374:1-5.
54. Chertov O, Ueda H, Xu LL, et al Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 1997;186:739-747.
55. Anger T, Klintworth N, Stumpf C, et al RGS protein specificity towards Gq- and Gi/o-mediated ERK 1/2 and Akt activation, in vitro. J Biochem Mol Biol 2007;40:899-910.